Studies have shown that the mRNA and protein levels of TGF-β1 were significantly upregulated in patients with cirrhosis (26, 27), and TGF-β1 expression was higher in tumor tissues of HCC (28–30). This evidence concerns the gene TGFB1 and hepatocellular carcinoma.